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Abstract
Background: Determining the cause of effusions is challenging and might require a 
biopsy. Whether cell blocks from effusions are representative of biopsies requires 
investigation. A previously developed immunohistochemical panel aids in the differ-
entiation of hyperplastic and neoplastic mesothelium in canine biopsies but has not 
been investigated in effusions.
Objectives: The study aimed to assess cell blocks as an alternative to biopsies and de-
termine whether immunohistochemistry helps distinguish hyperplastic mesothelium, 
mesothelioma, and carcinoma.
Methods: Effusions and biopsies were collected from five dogs with mesothelial 
hyperplasia (group MH), six with mesothelioma (group M), and five with carcinoma 
(group C). Immunohistochemistry (IHC) for cytokeratin, vimentin, Wilm's tumor pro-
tein 1 (WT1), desmin, glucose transporter 1 (GLUT1), and insulin- like growth factor 
II mRNA- binding protein 3 (IMP3) was performed. Sections were scored for staining 
intensity and the percentage of positively stained cells.
Results: In paired cell blocks and biopsies, vimentin and WT1 staining were positively 
correlated for intensity and the percentage of positive cells, although not all paired 
results were identical. The intensity of IMP3 staining in cell blocks was higher in 
group M than in group C (P = 0.012), and WT1 staining was higher in group MH than 
in group C (P = 0.020). For biopsies, the intensity of WT1 staining was higher in group 
MH than in group C (P = 0.031). In group C, WT1 was negative in all cell blocks and 
biopsies, and desmin was negative in four of five cases.
Conclusions: IHC results for the cell blocks and biopsies were comparable for poten-
tially useful markers, such as WT1, which helped discriminate between groups. IHC 
provided additional information, although results were not always definitive. Further 
studies on a larger population are required.
This is an open access article under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs License, which permits use and distribution in any 
medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
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1  | INTRODUC TION
Body cavity effusions are common in dogs and can occur in 
mesothelial- lined cavities such as the pericardial, pleural, and perito-
neal spaces. Routine investigation includes fluid analysis for macro-
scopic appearance, a total nucleated cell count (TNCC), total protein 
(TP) concentration, and cytologic examination allowing classification 
as a transudate, modified (or high- protein) transudate, or exudate.1 
In veterinary medicine, cytologic abnormalities such as inflammatory 
cell infiltrates, neoplastic cells, reactive mesothelial cells, and etio-
logic agents can help determine the cause, but the diagnosis often 
remains unclear; in one study, the diagnostic sensitivity of effusion 
cytology for malignancy in dogs and cats was 60%.2 Determining the 
nature of atypical cells is a particular challenge. Reactive (hyperplas-
tic) mesothelial cells can exhibit several atypical features and can be 
difficult to differentiate from mesothelioma and carcinoma on cy-
tologic examination and even histologic examination of biopsies.3,4 
Pericardial fluid also has the disadvantage that mesothelial cells can 
become highly reactive in this site, sometimes mimicking neoplasia.5 
In human pathology, cytomorphologic features that distinguish re-
active mesothelial cells, mesothelioma, and carcinoma have been 
described for conventional cytology,6 but the use of cytology alone 
remains controversial.7,8 For instance, the sensitivity of cytologic 
examination for the diagnosis of mesothelioma in human samples 
varies substantially from 4% to 77%.9
Immunohistochemistry (IHC) panels have been developed to 
differentiate these conditions in human patients.8,10 Using IHC 
for glucose transporter 1 (GLUT1) and insulin- like growth factor II 
mRNA- binding protein 3 (IMP3) in biopsies, a sensitivity of 100% and 
specificity of 95% were described for distinguishing mesothelioma 
from reactive mesothelial cells.11 However, this was based on statis-
tical probability, and IHC might not always be useful in an individual 
patient.12 Wilm's tumor protein 1 (WT1), a tumor suppressor gene, 
is recognized as a reliable marker for mesothelial cells in human pa-
thology, with 70%- 95% of mesotheliomas showing positive nuclear 
staining and lung adenocarcinomas being negative,8 although it does 
not distinguish between hyperplastic mesothelium and mesotheli-
oma. Desmin IHC, however, is considered of value in distinguishing 
hyperplastic and neoplastic mesothelial cells in human patients, with 
positive and negative staining, respectively, and a sensitivity of 84% 
and specificity of 94%.13
We previously described an IHC panel comprising cytokeratin 
(CK), vimentin (vim), IMP3, and GLUT1 to aid in distinguishing re-
active mesothelial cells, atypical mesothelial proliferation, and me-
sothelioma in canine pericardial biopsies.14 Although not definitive 
in all cases, the panel was considered a valuable addition to routine 
investigation. Applying this and other IHC panels to cells in cavitary 
effusions could provide a minimally invasive means of determining 
the histogenesis of atypical cells. This could be accomplished by IHC 
on effusions prepared as cell blocks, which has been well established 
in human pathology for this purpose, including distinguishing ade-
nocarcinoma, reactive mesothelial cells, mesothelioma, and carci-
nomas.13,15- 18 In veterinary pathology, cell block IHC is a relatively 
new technique but has been used for distinguishing carcinoma, 
mesothelial cells, and lymphoma in cavitary effusions in dogs and 
cats.19,20 However, our recently described IHC panel to aid in distin-
guishing benign from malignant mesothelial proliferations in biopsies 
from dogs14 has not been applied to cell blocks. Other markers of 
potential value are WT1 and desmin. WT1 IHC has been validated 
as a means of distinguishing mesothelial cells from carcinoma in cell 
blocks from canine patients.21 It did not distinguish reactive from 
neoplastic mesothelial cells but was consistently positive in both 
conditions. Desmin was found to be of limited value in previous 
studies on canine mesothelioma in immunocytochemistry (ICC)22 
and pericardial biopsies14 but has not been investigated in cell blocks 
for distinguishing reactive and neoplastic mesothelium and carci-
noma in dogs.
The primary aim of this initial prospective study was to determine 
whether cell block IHC provides similar results to the corresponding 
biopsy IHC in canine mesothelioma, mesothelial hyperplasia, and 
carcinoma using a panel of six antibodies and, therefore, to provide 
as a proof of principle, the use of cell block IHC of cavitary effusions 
as an alternative to biopsy. The secondary aim was to assess whether 
this panel is of value in distinguishing these diseases.
2  | MATERIAL S AND METHODS
2.1 | Animals
The dogs were clinical cases referred to the Universities of 
Edinburgh, Liverpool, and Porto. The study was approved by the 
Veterinary Ethical Review Committee of each university (approval 
nos. 11/16, 410, and 237/2017 respectively), and informed con-
sent for the use of excess samples for research was given by all 
owners. Inclusion criteria were an effusion in one or more of the 
pericardial, pleural, or peritoneal cavities, in which cells with some 
features consistent with mesothelial cells (either reactive or neo-
plastic) or carcinoma were detected on fluid cytology, and where 
a definitive diagnosis was made on biopsy examination. Exclusion 
criteria were cases in which the final diagnosis was not completely 
certain or where insufficient fluid was available. Cases diagnosed 
on biopsy as atypical mesothelial proliferations, considered to be 
intermediate between hyperplasia and mesothelioma,23 were also 
excluded from the study, as categorization of these proliferations 
is controversial.
K E Y W O R D S
canine, carcinoma, cell block, IMP3, mesothelioma, WT1
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2.2 | Routine fluid analysis
The collection of effusions was carried out by standard methods,24 
and routine fluid analysis was undertaken. The TNCCs were com-
pared between groups. Cytologic examination was carried out on 
the day of collection by board- certified clinical pathologists at each 
university after staining direct smears and/or cytocentrifuge prepa-
rations and staining with May- Grünwald Giemsa (MGG) or modified 
Wright Giemsa stains. The designation of the cells in fluids as reac-
tive mesothelial cells, mesothelioma, or carcinoma was based on the 
experience of the clinical pathologists.
2.3 | Cell blocks and biopsies
The cell blocks were made at the university where each dog was exam-
ined, using methods already established at each site. At the University 
of Edinburgh, effusion fluid (2 mL, although on some occasions less if 
only a small sample was received) was placed in a 2- mL conical plastic 
tube (Eppendorf) and centrifuged at 1260g for 7 minutes (Biofuge 13, 
Heraeus GmbH). The supernatant was removed, leaving the cell pellet, 
and replaced with 2 mL of 10% phosphate- buffered formalin (pH 7.4), 
mixed using a RotaMix vortexer (Hook & Tucker Instruments Ltd.). The 
sample was left at room temperature for 1 hour. Centrifugation was then 
repeated. The supernatant was removed, replaced with 2 mL of a 2% 
solution of agarose ([Noble agar, cat. No. A543, Sigma- Aldrich Ltd.] dis-
solved in distilled H2O and mixed with an equal volume of borate buffer 
[0.5 M, pH 8.6]) warmed to 50°C. The pellet was vortexed, and then the 
tube was centrifuged at 1260g for 7 minutes. The tube was kept at 4°C 
for 30 minutes, and then the agarose cell pellet was removed by cutting 
the tip off the tube and pushing it out at the top. The cell block was cut 
in two pieces longitudinally, and both halves were processed to a paraf-
fin wax block using standard methods. At the University of Liverpool, a 
1.3 mL aliquot of the fluid was placed in a plastic 1.5- mL Eppendorf tube 
and centrifuged for 5 minutes at 1200g (IEC Micromax, Thermo Fisher 
Scientific). The supernatant was removed, and 0.5 mL of 10% neutral 
buffered formalin was added, and the pellet was fixed for 24 hours. 
The cell blocks from the University of Porto were made using microhe-
matocrit tubes, as previously described.20 No binding agents (agarose 
or other) are used in the methods established at the Universities of 
Liverpool and Porto. The cell pellet is typically compact enough to be 
removed from the Eppendorf tip using forceps (Liverpool) and from the 
microhematocrit tube using a paper clip (Porto) before being placed into 
the molten paraffin wax within an embedding mold.
All tissue biopsies used for comparison had been fixed in 10% 
phosphate- buffered formalin (pH 7.4) and embedded in paraffin wax 
by routine methods.
2.4 | H&E staining and assessment
Sections of cell blocks and biopsies were cut 4 µm thick and stained 
with H&E for a description of the cell morphology in the case of 
the cell blocks, and the tissue architecture of the biopsy sections. 
Where more than one tissue was sampled, these were processed in 
the same block. The biopsies were originally examined by the duty 
pathologists and reviewed by the study pathologists (EM, LR, RM, 
and MS) at each university.
2.5 | Immunohistochemistry
Sections (4 or 5 µm depending on the laboratory) of cell blocks and 
biopsies were placed on SuperFrost Plus coated slides (Thermo 
Electron Ltd.), dewaxed, hydrated, and rinsed in distilled water. 
The methods for CK, vim, IMP3, and GLUT1 were as previously de-
scribed.14 Briefly, nonspecific endogenous peroxidase was blocked 
with the REAL blocking agent (S202386, Dako Ltd.). All antibodies 
were diluted in the antibody diluent (S0809, Dako). For CK, a mouse 
monoclonal anti- cytokeratin antibody, clone MNF116 (M0821, 
Dako), was diluted 1/50 following antigen retrieval using proteinase 
K (S3020, Dako). For vim, a mouse monoclonal anti- vimentin anti-
body clone V9 (NCL- L- VIM- V9, Novocastra Laboratories) was diluted 
1/400 following antigen retrieval using high pH antigen unmasking 
buffer (H- 3300, Vector Laboratories Ltd.). Toward the end of the 
study, sections were stained with a mouse monoclonal anti- vimentin 
antibody clone V9 (M0725, Dako) diluted 1/7000 due to reagent 
availability.
For GLUT1, a rabbit polyclonal anti- GLUT1 antibody (15309, 
Abcam Ltd.) was diluted 1/500, and following antigen retrieval 
using 0.01 M citrate buffer at pH 6.0. For IMP3, a mouse monoclo-
nal anti- IMP3 antibody clone 69.1 (M3626, Dako) was diluted 1/50 
followed by antigen retrieval using high pH antigen unmasking 
buffer (H- 3300, Vector). The sections were then incubated with a 
secondary antibody (Envision anti- mouse HRP [K4007] or Envision 
anti- rabbit HRP [K4011], Dako, as appropriate), visualized with the 
DAB+chromogen (K3468, Dako). The method for WT1 was as pre-
viously described21; mouse monoclonal anti- human WT1 antibody 
clone 6F- H (Dako) diluted 1/150 was used, and antigen retrieval was 
performed in a 100°C water bath, with a polymer detection system 
(Novocastra). For desmin, a mouse monoclonal anti- desmin anti-
body clone DE- R- 11 (NCL- L- DES- DER11, Novocastra Laboratories) 
was diluted 1/800 following antigen retrieval in a 100°C water 
bath in EDTA; the polymer detection system (Novocastra) was also 
used. All stained sections were counterstained with Harris hema-
toxylin. Positive controls were canine esophagus (GLUT1), stomach 
(IMP3), skin, liver, intestine, and kidney (CK), intestine (vim and de-
smin), human mesothelioma, and kidney (WT1). Negative controls 
were sections processed with antibody diluent in place of the pri-
mary antibody.
The validation of mouse monoclonal anti- cytokeratin antibody 
clone MNF116 and mouse monoclonal anti- vimentin antibody clone 
V9 has been previously described for canine tissues.25,26 The val-
idation of the rabbit polyclonal anti- GLUT1 antibody and mouse 
monoclonal anti- IMP3 antibody clone 69.1 for canine tissues was 
previously cited.14 The validation of mouse monoclonal anti- WT121 
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and mouse monoclonal anti- desmin clone DE- R- 1127 has also been 
described for canine tissues.
2.6 | Cell block and biopsy scoring
The sections of blocks and biopsies were scored semiquantita-
tively for % positive cells as 0 = completely negative, 1 = 1%- 25% 
of cells positive, 2 = 26%- 50% positive, 3 = 51%- 75% positive, and 
4 = ≥ 75% positive. Intensity of staining was scored as 0 = negative, 
1 = weakly positive (barely visible specific stain), 2 = moderately 
positive (between mild and strong), or 3 = strongly positive (compa-
rable with positive control staining). Where more than two tissues 
were sampled from the same case, these were scored together. The 
slides were initially scored independently by two pathologists (EM 
and LR), and a consensus was reached when scores were initially 
discordant. Intra- observer variation in IHC scoring was assessed 
separately for the intensity of staining and percentage of positively 
staining cells for the cell blocks and biopsies using the original scores 
before modification reached by a consensus. The pathologists were 
blinded to the initial cytologic diagnosis. In carcinoma cases, scoring 
was restricted to the main population of interest, that is, the neo-
plastic cells as identified in H&E sections, and not any mesothelial 
cells present. When discrepancies in the stain intensity scoring of 
more than 2 units occurred between cell blocks and corresponding 
biopsies, restaining was undertaken to ensure that the difference 
was not due to laboratory error. However, in each case where this 
was undertaken, the discrepancy was found to be consistent.
2.7 | Statistics
In each disease group, the ages of dogs at the time of clinical inves-
tigation were normally distributed (Shapiro- Wilk tests). The average 
age of dogs and TNCC of the fluids in each group were compared 
using a one- way ANOVA followed by multiple comparison tests.
To compare IHC scores for paired cell blocks and biopsies, the 
ordinal scores for the intensity of staining and percentage of cells 
positive for each antibody marker were compared across carcinoma, 
mesothelial hyperplasia, and mesothelioma groups using nonpara-
metric Spearman correlation tests.
The linearly weighted kappa values were calculated using the 
statistical language R, version 3.6.2 (R Foundation for Statistical 
Computing) to assess intra- observer variability in IHC scoring.
To identify IHC markers that discriminate between disease enti-
ties, we compared IHC scores for the intensity of staining and per-
centage of cells positive with nonparametric Kruskal- Wallis tests 
followed by Dunn's multiple comparisons tests. Graphs represent 
the median score as a histogram bar and error bars as the interquar-
tile range. Statistical analysis was carried out using GraphPad Prism 




The signalment of the cases is summarized in Table 1. A range of 
breeds and sexes were represented, and group C dogs were signifi-
cantly older than group M dogs (P = 0.030). Sixteen cases met the 
inclusion criteria, including 13 with pleural, two with pericardial, 
and one with peritoneal effusion. The 16 cases were divided into 
the following groups on the basis of standard histologic examination 
of biopsies: mesothelial hyperplasia (MH) (n = 5), mesothelioma (M) 
(n = 6), and carcinoma (C) (n = 5). For one case of mesothelial hyper-
plasia and one of mesothelioma, the paraffin wax blocks were lost 
before WT1 or desmin staining were performed.
3.2 | Cytology
The TNCCs were not significantly different between groups (Table 1). 
Examples of MGG- stained slides are shown in Figure 1A,C. In group 
MH, the main cytologic features were individualized, paired, and co-
hesively clustered, and pseudoacinar arrangements of mesothelial 
TA B L E  1   Summary of signalment, diagnoses, and total nucleated cell count of effusions in MH (mesothelial hyperplasia), M 
(mesothelioma), and C (carcinoma) groups
Group
Age in years 
(mean and SD) Sex Breeds
Effusion nucleated cell count 
(mean and SD, ×109/L)
MH (n = 5) 8.6 ± 1.7 F (1), FN (1), M (2), MN (1) English cocker spaniel, Labrador, Golden 
retriever, Great Dane, Rhodesian 
ridgeback (1 each)
11.2 ± 5.6
M (n = 6) 7.0 ± 3.9 F (1), FN (1), M (4) Golden retriever (2), Labrador, Border collie, 
GSHP, Mastiff (1 each)
6.9 ± 5.8
C (n = 5) 12.6 ± 3.3 F (3), M (1), MN (1), x bred (4), Labrador (1) 10.1 ± 10.9
Note: Group C was significantly older than group M (P = 0.030; one- way ANOVA followed by multiple range tests); other age comparisons between 
groups were not statistically significant. There was no significant difference in total cell counts between groups (P = 0.612; one- way ANOVA [cell 
count not done for one case in group C]) F, entire female; FN, neutered female; M, entire male; MN, neutered male; x bred, crossbred; GSHP, German 
shorthaired pointer.
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cells with moderate to marked anisocytosis and anisokaryosis, often 
with a prominent pink fringe of microvilli at the cell border, consid-
ered to correspond with the glycocalyx. Occasionally, pink eosino-
philic extracellular material was observed within the cell clusters, 
corresponding to the so- called collagenous cores. The cytoplasm 
was medium to deep blue with round to oval, central to eccentric nu-
clei, stippled chromatin, and variably sized nucleoli. Vacuoles were 
sometimes present, occasionally displacing the nucleus. Moderate 
numbers of bi- or multinucleated cells were present, with occasional 
mitoses.
In group M, mesothelial cells were individualized or in nests, sheets, 
and pseudoacinar structures with small to large amounts of medium 
to deep blue staining, sometimes vacuolated cytoplasm. Occasional 
cells had pink, granular material in the vacuoles. The nuclei were round 
to oval, medium- sized to very large, and bi- and multinucleation were 
frequently seen, sometimes with nuclear molding. The nucleoli ranged 
from one small nucleolus to multiple, large, and prominent nucleoli, and 
anisonucleoliosis was common. Anisocytosis and anisokaryosis were 
moderate to marked, and occasional mitoses were seen.
Cytologic findings in group C consisted of individuals and cohe-
sive three- dimensional sheets, nests, and pseudoacinar structures of 
small to large epithelial cells, with moderate to marked anisocytosis 
and anisokaryosis. The cells had a moderate to large amount of me-
dium to deep blue cytoplasm, sometimes with vacuoles and/or pink 
granules, and the nuclei were medium to large and round to oval with 
stippled chromatin and one to multiple variably sized, round nucleoli. 
Nuclear molding, multinucleated cells, and mitoses were sometimes 
observed.
3.3 | H&E staining in cell blocks and biopsies
Samples in group MH were comprised of five incisional biopsies (1 at 
necropsy) of thickened pleura (3) or pericardium (2). Those in group 
M were comprised of incisional (3), excisional (2), or Trucut (Merit 
Medical Systems Inc) biopsies (1) of a thoracic wall mass (2), thick-
ened pleura (2), thickened mediastinum (1), or lung mass (1). Group C 
samples consisted of five excisional biopsies (4 at necropsy) of a lung 
F I G U R E  1   Cytology and corresponding cell block preparations of cavitary effusions from mesothelioma and carcinoma cases. A, 
mesothelioma cytology; B, mesothelioma cell block from the same case as A; C, carcinoma cytology; D, carcinoma cell block. The carcinoma 
cell block shows tubular “mini biopsies,” consistent with adenocarcinoma. Cytologic samples stained with May- Grünwald Giemsa and cell 
block sections with H&E, ×40 objective
A B
C D
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mass (2), mammary carcinoma and pleural mass (2), and prostatic 
mass with peritoneal nodule (1).
Examples of H&E- stained cell blocks are shown in Figure 1B,D. 
Sections from group MH contained individuals, clusters, pseudoaci-
nar structures, and rarely more elongated arrangements of reactive 
mesothelial cells with mild to marked anisocytosis and anisokary-
osis. Variable amounts of the cytoplasm and round to oval nuclei 
were also seen. One or more prominent nucleoli and multinucleation 
were also occasionally present, whereas binucleation was commonly 
found. In group M, the arrangement of the clusters were often more 
irregular than in group MH, although round clusters and pseudo-
acini were sometimes seen. The cytoplasm was often vacuolated. 
Multiple nucleoli and bi- or multinucleation were more common in 
group M than MH. In group C, the findings were variable. Cohesive 
clusters of medium- sized to large epithelial cells with marked aniso-
cytosis and anisokaryosis were evident. Irregular, elongated, and 
sometimes pseudoacinar structures, as well as individual cells were 
also present, with a lack of features (eg, a pink fringe of microvilli at 
the cell border) that would suggest mesothelial origin. However, the 
cell morphology based solely on H&E staining was poorly discrimi-
natory between the groups.
The histologic features of the biopsies in groups MH and M were 
as previously described.14,23 Cases of atypical mesothelial prolifera-
tion, considered to be intermediate between hyperplasia and meso-
thelioma,23 were not included in the study. The biopsies in group C 
presented features typical of carcinoma and consisted of mammary 
carcinoma (n = 2), pulmonary adenocarcinoma (n = 2), and prostatic 
carcinoma (n = 1).
After determining the definitive diagnoses by histologic exam-
ination, of the five cases in group MH, the original cytologic diagno-
sis was mesothelial hyperplasia (4 cases) and mesothelial hyperplasia 
or mesothelioma (1 case). Of the six cases in group M, the cytologic 
diagnosis was neoplastic effusion (2 cases), atypical mesothelial pro-
liferation (2 cases), carcinoma or mesothelioma (1 case), and meso-
thelioma (1 case). Of the five cases in group C, the original cytologic 
diagnosis was carcinoma (4 cases) and mesothelial hyperplasia (1 
case). Overall, the sensitivity of fluid cytology for obtaining a cor-
rect definitive diagnosis in the study population was 56% (9/16). 
Due to the nature of the cytologic diagnoses, which sometimes in-
cluded more than one differential diagnosis, it was not possible to 
accurately determine false positives and true negatives and hence to 
accurately calculate specificity.
3.4 | Immunohistochemistry in cell 
blocks and biopsies
The expected staining pattern for the six IHC methods in each 
group is shown in Table 2, and the individual dog scores are shown 
in Table S1. Examples of IHC of cell block sections are shown in 
Figures 2 and 3, and the summary of the scores for the intensity of 
staining and percentage of positive cells on IHC for CK, vim, IMP3, 
GLUT1, WT1, and desmin in the cell blocks and the corresponding 
biopsies, with statistical comparisons, is shown in Figure 4. Where 
positive staining was present, CK, vim, and IMP3 showed intracyto-
plasmic staining; GLUT1 and desmin staining showed both cytoplas-
mic and membranous staining; and WT1 showed nuclear staining.
In paired cell blocks and biopsies, vim and WT1 staining were 
positively correlated between the two sample types for inten-
sity and the percentage of positive cells; furthermore, CK and 
IMP3 staining were correlated for the percentage of positive cells 
(Table 3). Although these correlations suggest broad comparability 
of cell blocks and biopsies for this subset of antibody markers, indi-
vidual pairs of results were not all identical (Figure 4).
Comparisons of markers between disease groups showed that 
for cell blocks, the intensity of IMP3 staining was significantly higher 
in group M than in group C (P = 0.012), and intensity of WT1 staining 
and percentage of cells stained for WT1 was higher in group MH 
than in group C (P = 0.020 and P = 0.006, respectively). For biopsies, 
the intensity and percentage of cells positive for WT1 staining were 
also higher in group MH than in group C (P = 0.031 and 0.025, re-
spectively). For desmin, the staining intensity in biopsies was higher 
in group MH than in group C (P = 0.025). WT1 was negative in cell 
blocks and biopsies from all cases in group C. However, WT1 was 
also negative in one cell block and one biopsy in group M. Desmin 
was negative in four of five cell blocks and biopsies from group C 
compared with one of four cell blocks and none of four biopsies in 
group MH, and two of five cell blocks and one of five biopsies in 
group M. In addition, cases in groups MH and M were also occasion-
ally negative for desmin in cell blocks or biopsies (Table S1).
The weighted kappa values with 95% confidence intervals for 
intra- observer variability were: staining intensity in cell blocks 
0.797 (0.638- 0.955), percentage of cells stained in cell blocks 0.889 
(0.794- 0.984), staining intensity in biopsies 0.862 (0.682- 1.042), and 
percentage of cells stained in biopsies 0.896 (0.744- 1.048). These 
values confirmed almost perfect agreement between observers.
4  | DISCUSSION
In this study, the IHC results for cell blocks from cases of mesothelial 
hyperplasia, mesothelioma, and carcinoma were not significantly dif-
ferent from the corresponding biopsies. The results also confirmed 
the difficulty in distinguishing these diseases using conventional 
cytology, especially mesothelioma vs mesothelial hyperplasia, and 
the potential value of cell block IHC, a minimally invasive tech-
nique, using a combination of two recently described IHC panels in 
dogs.14,21
Cytology alone had a diagnostic sensitivity of 56%, slightly lower 
than a previous report of 60%.2 The sensitivity in the present study 
was biased by the relative difficulty in diagnosing mesotheliomas by 
cytology alone and the overrepresentation of these tumors com-
pared with the prevalence expected in clinical practice. In a series 
of 304 effusions, mesothelioma comprised only 0.7% of cases,28 and 
in a large series of dogs submitted for necropsy, it comprised 0.2% 
of cases.29 However, it was clear from the morphologic descriptions 
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that there was considerable overlap between categories, especially 
mesothelial hyperplasia and mesothelioma, confirming the require-
ment for the use of immunologic techniques.
Previously, ICC, the application of immunological stains to fluid 
smears, has been used for cavitary fluid analysis in veterinary med-
icine.30,31 The main advantages of ICC over conventional IHC on bi-
opsies are the use of a less invasive technique, rapidity of results, 
and the potential to use antibodies that cannot be used on formalin- 
fixed tissues.31 However, ICC has a number of significant disadvan-
tages. Storage times before antigen loss is limited,32 maintaining a 
consistent bank of positive control slides is difficult, cell numbers 
can be low, and the amount of background stain can be high.33 In 
addition, as the number of slides could be limited, further material 
is unlikely to be available from the sample for future diagnostic in-
vestigations, for example, further immunostaining.31 The limitations 
of ICC have led to the introduction of cell block techniques that 
allow the advantages of IHC to be combined with a relatively non-
invasive method of collection. An additional feature of cell blocks is 
the potential presence of “mini biopsies,” where some architecture 
is evident in exfoliated tissue fragments,34 a finding confirmed by 
our study. We found these structures to be of some value in making 
differential diagnoses and were helpful in identifying relevant areas 
for IHC assessment (Figure 1D).
The results in paired cell blocks and biopsies show that vim and 
WT1 staining were positively correlated between the two sample 
types for scores of staining intensities and percentage of positive 
cells. WT1 staining appears to be useful in discriminating between 
mesothelial hyperplasia and carcinoma. Taken together, these re-
sults suggest that IHC of effusions can provide results represen-
tative of the underlying abnormalities for some markers. However, 
it was clear from detailed comparisons between groups that the 
results for paired cell blocks and biopsies were not identical, and 
while statistics help identify promising markers for differential di-
agnosis, they are not absolutely definitive when assessing results 
in individual patients.12 In some cases, cell blocks or biopsies gave 
unexpected results for the disease category. These variations could 
be due to processing, for example, more prolonged contact with 
formalin for biopsies compared with cell blocks, differences in the 
degree to which the cells exfoliate into the fluid, or different antigen 
expression by exfoliated cells in fluids compared with those in solid 
tissues. In addition, reactive mesothelial cells were often present in 
cell blocks from mesothelioma and carcinoma effusions, and some 
of these cells might have been included in the scoring of the main 
cell population of interest. However, the fact that the cells tend to 
be layered in the cell blocks into erythrocytes, neoplastic cells, and 
smaller mesothelial cells/inflammatory cells aided in differentiation.
Strong CK staining was obtained in all groups, as expected. There 
were no significant differences between groups for vim staining, al-
though there were trends toward higher staining intensity in groups 
MH and M than in group C (Figure 4). This is broadly consistent with 
the expected finding of positive CK and vim staining in mesothelial 
cells. In most group C cases, the expected positive CK and nega-
tive or weak vim staining were obtained in cell blocks and biopsies. 
Previous studies in cats and dogs have shown CK and vim to be of 
value in differentiating mesothelial from epithelial cells,19,35 but 
these studies did not distinguish hyperplastic from neoplastic me-
sothelial cells. Similarly, the detection of carcinoma metastasis on 
bone marrow cell blocks has been described in dogs and cats, but 
only CK IHC was used.36 Unexpected results sometimes occurred 
in the present study, for example, negative staining for vim in one 
mesothelioma case. However, this is likely due to the altered expres-
sion of these antigens by the neoplastic cells rather than technical 
failure, especially as this individual also had negative vim staining on 
a biopsy processed on a different day.
Higher WT1 and desmin staining intensity were generally seen in 
cells of mesothelial origin. It was notable that WT1 was negative in all 
group C cases. Negative WT1 staining in carcinomas is not surpris-
ing given that it is expressed in mesoderm- derived cells,37 and the 
value of WT1 for identifying mesothelial cells, either hyperplastic or 
neoplastic, has been described in people8 and dogs.21 However, it is 
clear that negative WT1 staining was not completely specific to car-
cinomas as it occasionally occurred in group M. Only nuclear staining 
for WT1 was considered positive,21 because cytoplasmic staining is 
less specific37 and has been described in canine lymphoma.38
Results for desmin were similar to those for WT1 in that carcino-
mas were usually negative (4/5 cases), whereas desmin was negative 
in only one of four cell blocks and none of four biopsies in group 
MH, and two of five cell blocks and one of five biopsies in group M. 
TA B L E  2   Expected immunohistochemical staining results in cases of mesothelial hyperplasia, mesothelioma, and carcinoma for each of 
the six markers used in the study
Marker Group MH Group M Group C Comments
Cytokeratin ++ ++ ++ Cytoplasmic
Vimentin +/++ −/+/++ − Cytoplasmic; staining in M usually positive but can 
be variable; in some C, vimentin- positive cells 
may occur
IMP3 − ++ − Cytoplasmic
GLUT1 + +/++ Variable Cytoplasmic and membranous
WT1 ++ ++ − Nuclear
Desmin ++ ++ − Cytoplasmic and membranous
Abbreviations: C, carcinoma; M, mesothelioma; MH, mesothelial hyperplasia.
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Lack of desmin staining on ICC in canine serosal cavity carcinomas 
and variably positive staining in cells of mesothelial origin has been 
previously reported.35 Desmin is reported to aid in differentiating 
hyperplastic and neoplastic mesothelial cells in people, with stron-
ger staining in benign mesothelial proliferations,13,39 but this was not 
evident in the present study. Furthermore, desmin was ineffective 
F I G U R E  2   A- F, Immunohistochemistry on a pleural fluid cell block and biopsy (insets) from a case of mesothelioma; for each image, the 
intensity of staining of the cell block is followed by the intensity of the biopsy. (A) Cytokeratin (2,3); (B) Vimentin (2,3); (C) IMP3 (3,3); (D) 
GLUT1 (1,3); (E) Desmin (1,3); and (F) WT1 (3,3). The results are similar in the cell blocks and biopsies, except for GLUT1 and desmin where 
staining was more intense in the biopsies. The strong WT1 staining is typical of mesothelial cells and strong IMP3 of mesothelioma (see text 
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in distinguishing hyperplastic mesothelium from mesothelioma in 
canine pericardial biopsies.14 Thus, while desmin and WT1 did not 
distinguish hyperplastic from neoplastic mesothelium, the fact that 
carcinomas were always (WT1) and usually (desmin) negative indi-
cates that these markers could be of value in IHC panels and might 
be most value in cases where cytology or standard H&E staining 
F I G U R E  3   A- F, Immunohistochemistry on a pleural fluid cell block and biopsy (insets) from a case of mesothelial hyperplasia; for each 
image, the intensity of staining of the cell block is followed by the intensity of the biopsy. (A) Cytokeratin (3,3); (B) Vimentin (3,3); (C) 
IMP3 (0,0); (D) GLUT1 (3,0); (E) Desmin (2,2); and (F) WT1 (3,3). The results are similar in the cell blocks and biopsies except for GLUT1, 
where staining was more intense in the cell block. The strong WT1 staining is typical of mesothelial cells, and negative IMP3 is typical of 
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show clear criteria of malignancy, with the main dilemma of differen-
tiating mesothelioma from carcinoma. Furthermore, as vim staining 
was not invariably positive in mesothelial tissue and could even be 
positive in some carcinomas, a panel of CK, WT1, and desmin might 
be more reliable in this respect.
The results for IMP3 and GLUT1 were not identical to those re-
ported for canine pericardial biopsies in which IMP3 was of some 
value in aiding in the distinction of mesothelial hyperplasia, me-
sothelioma, and the intermediate category of atypical mesothelial 
proliferation.14 However, the intensity of IMP3 staining was signifi-
cantly higher in group M than in group C, at least in the cell blocks. 
There was also a trend toward greater intensity in group M than in 
group MH, as previously reported.14 Results for GLUT1 were similar 
in all three groups and did not appear to be a useful addition to the 
IHC panel, although GLUT1 is sometimes positive in canine meso-
thelioma where IMP3 is negative.14 Thus, there might be justification 
for including GLUT1 in more extended IHC panels to allow for the 
identification of such cases. In human pathology, a combination of 
IMP3 and GLUT1 staining has been recommended for distinguishing 
hyperplastic and neoplastic mesothelium10,11 although it could be 
difficult to interpret the results in individual cases40; such difficulties 
in interpretation are also likely to occur in dogs, as in our study. We, 
therefore, suggest that a more restricted panel of CK, WT1, desmin, 
and IMP3 might be of most value in distinguishing mesothelial hy-
perplasia, mesothelioma, and carcinoma in dogs until more specific 
markers are identified.
The major limitation of the study was the small number of cases, 
which reduced the statistical power. This was due to difficulty in ob-
taining well- documented paired cell block and biopsy samples. The 
exclusion criteria were rigidly applied to ensure that only confirmed, un-
equivocal cases were included, which involved discarding many samples 
where the diagnosis was likely but not confirmed beyond doubt. This 
approach was considered preferable to including cases that could have 
been incorrectly classified. In addition, clinicians usually did not proceed 
with biopsy when useful information had been obtained by effusion cy-
tology combined with IHC on cell blocks. Staining was also undertaken 
at three laboratories with slightly different methods, although in each 
individual case, the cell blocks and corresponding biopsies were treated 
in the same way. Further studies using a larger population are warranted 
to allow firmer recommendations to be made.
Overall, the differentiation between reactive and neoplastic me-
sothelium remains challenging, even with the proposed IHC panel. 
For the purpose of evaluating an IHC panel, we included a similar 
number of mesothelial hyperplasia, carcinoma, and mesothelioma 
cases. However, this does not reflect the clinical setting since meso-
thelioma is a rare neoplasm.
F I G U R E  4   IHC staining scores for antibody markers in cell blocks and biopsies. The histogram bar represents the median and the 
error bars represent the interquartile range. Purple = Mesothelioma group (n = 6 [n = 5 for WT1 and desmin]); green = Mesothelial 
hyperplasia group (n = 5 [n = 4 for WT1 and desmin]); yellow = Carcinoma group (n = 5). The sections of blocks and biopsies were scored 
semiquantitatively for % positive cells as 0 = completely negative, 1 = 1%- 25% of cells positive, 2 = 26%- 50% positive, 3 = 51%- 75% 
positive, and 4 = ≥ 75% positive. The intensity of staining was scored as 0 = negative, 1 = weakly positive (barely visible specific stain), 
2 = moderately positive (between mild and strong), or 3 = strongly positive. Data were analyzed using Kruskal- Wallis tests followed by 
Dunn's multiple comparison tests. Two- tailed tests: *P < 0.05, **P < 0.01, all other tests were nonsignificant P > 0.05. IHC markers: CK, 
cytokeratin; Vim, vimentin; IMP3; GLUT1; WT1; Desmin
TA B L E  3   Correlations between paired cell block and biopsy IHC scores for combined carcinoma, mesothelial hyperplasia, and 
mesothelioma cases
Marker Score Spearman r 95% confidence interval P
No. XY 
pairs
Cytokeratin Intensity NAa NAa NAa 16
% Positivity 0.6978 0.2943 to 0.8901 0.0083 16
Vimentin Intensity 0.7735 0.4376 to 0.9199 0.001 16
% Positivity 0.9222 0.7795 to 0.9739 <0.0001 16
IMP3 Intensity 0.4371 −0.09081 to 0.7732 0.0917 16
% Positivity 0.5985 0.1304 to 0.8484 0.016 16
GLUT1 Intensity - 0.2069 −0.6467 to 0.3361 0.4484 16
% Positivity - 0.3093 −0.7062 to 0.2354 0.2725 16
WT1 Intensity 0.6234 0.1215 to 0.8714 0.0284 14
% Positivity 0.8287 0.5193 to 0.9460 0.0022 14
Desmin Intensity 0.3469 −0.2417 to 0.7488 0.2266 14
% Positivity 0.2328 −0.3551 to 0.6888 0.4186 14
Note: Correlations between ordinal IHC scores were analyzed with Spearman rank correlation tests.
aNA not applicable as the intensity of CK staining was uniformly high.
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5  | CONCLUSIONS
Immunohistochemistry on cell blocks derived from cavitary ef-
fusions is a simple technique that often provided additional infor-
mation on identifying mesothelial hyperplasia, mesothelioma, and 
carcinoma. An IHC panel of CK, WT1, desmin, and IMP3 appeared 
to be of most value, with vim and GLUT1 being less useful. The 
panel is not of value in every case, but its use on cell blocks can be 
a first approach before considering surgical biopsy and would have 
safety benefits, since fluid collection is minimally invasive and per-
formed without general anesthesia. Once the cell blocks are made, 
additional tests, including further IHC and PCR, can be applied to 
individual cases, and they can be stored for many years, unlike fluid 
samples. Establishing a bank of cell blocks and biopsies to use as 
case controls for IHC staining and scoring and increasing population 
sizes for future studies will be important to standardize diagnoses 
and continue the search for more specific markers.
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